ArticleTranslational oncology2022

Therapeutic effects of an innovative BS-HH-002 drug on pancreatic cancer cells via induction of complete MCL-1 degradation.

A-Min Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.